'We don't have a vaccine that will do the job right now, something that will hold a year. That's one of the most important challenges,' says Pfizer's Albert Bourla.
Read this story at Fortune
'We don't have a vaccine that will do the job right now, something that will hold a year. That's one of the most important challenges,' says Pfizer's Albert Bourla.
Read this story at Fortune